Nano-drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NANO-DRUG INDUSTRY

2.1 Summary about Nano-drug Industry

2.2 Nano-drug Market Trends

2.2.1 Nano-drug Production & Consumption Trends

2.2.2 Nano-drug Demand Structure Trends

2.3 Nano-drug Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Liposomes 

4.2.2 Polymeric Micelles 

4.2.3 Solid lipid Nanoparticles 

4.2.4 Microemulsion and Nanoemulsion 

4.2.5 Nanosuspension

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Cancer and Tumors 

4.3.2 Autoimmune Disorders

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Liposomes 

5.2.2 Polymeric Micelles 

5.2.3 Solid lipid Nanoparticles 

5.2.4 Microemulsion and Nanoemulsion 

5.2.5 Nanosuspension

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Cancer and Tumors 

5.3.2 Autoimmune Disorders

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Liposomes 

6.2.2 Polymeric Micelles 

6.2.3 Solid lipid Nanoparticles 

6.2.4 Microemulsion and Nanoemulsion 

6.2.5 Nanosuspension

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Cancer and Tumors 

6.3.2 Autoimmune Disorders

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Liposomes 

7.2.2 Polymeric Micelles 

7.2.3 Solid lipid Nanoparticles 

7.2.4 Microemulsion and Nanoemulsion 

7.2.5 Nanosuspension

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Cancer and Tumors 

7.3.2 Autoimmune Disorders

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Liposomes 

8.2.2 Polymeric Micelles 

8.2.3 Solid lipid Nanoparticles 

8.2.4 Microemulsion and Nanoemulsion 

8.2.5 Nanosuspension

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Cancer and Tumors 

8.3.2 Autoimmune Disorders

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Liposomes 

9.2.2 Polymeric Micelles 

9.2.3 Solid lipid Nanoparticles 

9.2.4 Microemulsion and Nanoemulsion 

9.2.5 Nanosuspension

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Cancer and Tumors 

9.3.2 Autoimmune Disorders

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Merck 

10.1.2 Pfizer 

10.1.3 Novartis 

10.1.4 Abbott 

10.1.5 GlaxoSmithKline 

10.1.6 Roche 

10.1.7 Sanofi 

10.1.8 Eli Lilly 

10.1.9 Astrazeneca 

10.1.10 Johnson & Johnson 

10.1.11 Celgene 

10.1.12 Novavax 

10.1.13 Stryker 

10.1.14 Gilead Sciences 

10.1.15 OSI Pharmaceuticals 

10.1.16 Kadmon Pharmaceuticals 

10.1.17 Samyang Biopharm 

10.1.18 Mitsubishi Pharma 

10.1.19 Kaken Pharmaceutical 

10.1.20 Selecta Biosciences 

10.1.21 Par Pharmaceutical 

10.1.22 Cerulean Pharma 

10.1.23 Navidea Biopharmaceuticals 

10.1.24 Lummy

10.2 Nano-drug Sales Date of Major Players (2017-2020e)

10.2.1 Merck 

10.2.2 Pfizer 

10.2.3 Novartis 

10.2.4 Abbott 

10.2.5 GlaxoSmithKline 

10.2.6 Roche 

10.2.7 Sanofi 

10.2.8 Eli Lilly 

10.2.9 Astrazeneca 

10.2.10 Johnson & Johnson 

10.2.11 Celgene 

10.2.12 Novavax 

10.2.13 Stryker 

10.2.14 Gilead Sciences 

10.2.15 OSI Pharmaceuticals 

10.2.16 Kadmon Pharmaceuticals 

10.2.17 Samyang Biopharm 

10.2.18 Mitsubishi Pharma 

10.2.19 Kaken Pharmaceutical 

10.2.20 Selecta Biosciences 

10.2.21 Par Pharmaceutical 

10.2.22 Cerulean Pharma 

10.2.23 Navidea Biopharmaceuticals 

10.2.24 Lummy

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Nano-drug Product Type Overview

Table Nano-drug Product Type Market Share List

Table Nano-drug Product Type of Major Players

Table Brief Introduction of Merck 

Table Brief Introduction of Pfizer 

Table Brief Introduction of Novartis 

Table Brief Introduction of Abbott 

Table Brief Introduction of GlaxoSmithKline 

Table Brief Introduction of Roche 

Table Brief Introduction of Sanofi 

Table Brief Introduction of Eli Lilly 

Table Brief Introduction of Astrazeneca 

Table Brief Introduction of Johnson & Johnson 

Table Brief Introduction of Celgene 

Table Brief Introduction of Novavax 

Table Brief Introduction of Stryker 

Table Brief Introduction of Gilead Sciences 

Table Brief Introduction of OSI Pharmaceuticals 

Table Brief Introduction of Kadmon Pharmaceuticals 

Table Brief Introduction of Samyang Biopharm 

Table Brief Introduction of Mitsubishi Pharma 

Table Brief Introduction of Kaken Pharmaceutical 

Table Brief Introduction of Selecta Biosciences 

Table Brief Introduction of Par Pharmaceutical 

Table Brief Introduction of Cerulean Pharma 

Table Brief Introduction of Navidea Biopharmaceuticals 

Table Brief Introduction of Lummy

Table Products & Services of Merck 

Table Products & Services of Pfizer 

Table Products & Services of Novartis 

Table Products & Services of Abbott 

Table Products & Services of GlaxoSmithKline 

Table Products & Services of Roche 

Table Products & Services of Sanofi 

Table Products & Services of Eli Lilly 

Table Products & Services of Astrazeneca 

Table Products & Services of Johnson & Johnson 

Table Products & Services of Celgene 

Table Products & Services of Novavax 

Table Products & Services of Stryker 

Table Products & Services of Gilead Sciences 

Table Products & Services of OSI Pharmaceuticals 

Table Products & Services of Kadmon Pharmaceuticals 

Table Products & Services of Samyang Biopharm 

Table Products & Services of Mitsubishi Pharma 

Table Products & Services of Kaken Pharmaceutical 

Table Products & Services of Selecta Biosciences 

Table Products & Services of Par Pharmaceutical 

Table Products & Services of Cerulean Pharma 

Table Products & Services of Navidea Biopharmaceuticals 

Table Products & Services of Lummy

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Nano-drug Market Forecast (Million USD) by Region 2021f-2026f

Table Global Nano-drug Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Nano-drug Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Nano-drug Market Forecast (Million USD) Share by Demand 2021f-2026f